BCTX
Briacell Therapeutics
BCTX
BCTX
19 hedge funds and large institutions have $17.9M invested in Briacell Therapeutics in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more ownership
Funds ownership: 0.11% → 0.12% (+0%)
8% less capital invested
Capital invested by funds: $19.4M → $17.9M (-$1.52M)
Holders
19
Holding in Top 10
1
Calls
$906K
Puts
–
Top Buyers
| 1 | +$579K | |
| 2 | +$409K | |
| 3 | +$346K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$246K |
| 5 |
TWC
TD Waterhouse Canada
Toronto,
Ontario, Canada
|
+$90.3K |
Top Sellers
| 1 | -$446K | |
| 2 | -$77.4K | |
| 3 | -$75K | |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$25K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$18.8K |